Ralph DeFronzo

39PUBLICATIONS
60CO-AUTHORS
Molecular targetsMedical biochemistry - carbohydratesCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|May 27, 2026
Renal Lipotoxicity: Mechanisms and Therapeutic Perspectives.

|Apr 20, 2026
Response to Comment on Abdul-Ghani et al. One-Hour Plasma Glucose Predicts the Progression From Normal Glucose Tolerance to Prediabetes. Diabetes Care 2025;48:1273-1279.

|Dec 23, 2025
Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE).

Steven E Kahn, Mark Tripputi, John M Lachin

|Jul 15, 2025
Cushing Syndrome, Hypercortisolism, and Glucose Homeostasis: A Review.

Ralph A DeFronzo, Richard J Auchus

|Jul 08, 2025
Changes in β-Cell Function and Insulin Sensitivity During Treatment With Dapagliflozin Alone or in Combination With Exenatide in Type 2 Diabetes.

Curtis Triplitt, Eugenio Cersosimo, Mariam Alatrach

|Jun 23, 2025
Inadequately Controlled Type 2 Diabetes and Hypercortisolism: Improved Glycemia With Mifepristone Treatment.

Ralph A DeFronzo, Vivian Fonseca, Vanita R Aroda

Pageof 7

Frequent Collaborators

9 joint publications

Muhammad Abdul-Ghani

7 joint publications

Amalia Gastaldelli

7 joint publications

Muhammad Abdul-Ghani

6 joint publications

Steven E Kahn